Top Markets
Coin of the day
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc.

ACOR
Rank in Stocks #39255
Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering,... Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.
Share Price
$0.879
Last synced: 2024-05-07
Market Cap
$582.38K
Change (1 day)
9.88%
Change (1 year)
0.00%
Country
US
Trade Acorda Therapeutics, Inc. (ACOR)

Category

Stock price history for Acorda Therapeutics, Inc. (ACOR)
Highest end of day price: $0.85 on 2024-05-01

Lowest end of day price: $0.12 on 2006-02-01
Stock price history of Acorda Therapeutics, Inc. from 2006 to 2026
Annual Stock Price Performance
Year Performance
2024 273.49%
2023 16.42%
2022 -76.68%
2021 461.70%
2020 -60.58%
2019 15.75%
2018 -23.20%
2017 6.70%
2016 -50.07%
2015 2.84%
2014 26.97%
2013 20.82%
2012 10.61%
2011 -14.43%
2010 7.72%
2009 39.42%
2008 -12.57%
2007 21.88%
2006 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$162.50 25.72%
DE
$36.61 23.93%
JP
$227.34 40.15%
CH
$21.30 13.79%
IN